QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 发表日期：2017    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Comparison of efficacy and safety of first-line palliative chemotherapy with TX and XELOX regimens in patients with metastatic gastric adenocarcinoma: A randomized phase II trial 期刊论文 Journal of Clinical Oncology, 2017, 卷号: 35 作者:  Zhu X., Li J., Xiaoying Z., Guo W., Liu X., Zhang W., Chen Z., Qiu L., Li W., Huang M., Zhang X. 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Comparison of efficacy and safety of first-line palliative chemotherapy with TX and XELOX regimens in patients with metastatic gastric adenocarcinoma: A randomized phase II trial. 会议论文 作者:  Zhu, Xiaodong;  Li, Jin;  Zhao Xiaoying;  Guo, Weijian;  Liu, Xin 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文 作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 PRELIMINARY RESULTS OF EXTENDED FIELD IMRT CHEMO-RADIOTHERAPY OR PELVIC IMRT CHEMO-RADIOTHERAPY FOLLOWED BY OPERATION IN PATIENTS WITH MULTIPLE PELVIC LYMPH NODE METASTASIS(PHASE II CLINICAL TRIAL) 会议论文 作者:  Luo, W.;  Ke, G.;  Li, Y.;  Wu, X.;  Huang, X. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 PRELIMINARY RESULTS OF EXTENDED FIELD IMRT CHEMO-RADIOTHERAPY OR PELVIC IMRT CHEMO-RADIOTHERAPY FOLLOWED BY OPERATION IN PATIENTS WITH MULTIPLE PELVIC LYMPH NODE METASTASIS(PHASE II CLINICAL TRIAL) 会议论文 作者:  Luo, W.;  Ke, G.;  Li, Y.;  Wu, X.;  Huang, X. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 A phase II multicenter trial of the multitargeted kinase inhibitor sulfatinib in advanced medullary thyroid cancer (MTC) and radioiodine (RAI)-refractory differentiated thyroid cancer (DTC) 期刊论文 Journal of Clinical Oncology, 2017, 卷号: 35 作者:  Chen J., Ji Q., Cao J., Ji D., Bai C., Lin Y., Pan B., Sun G., Li J., Qi C., Hua Y. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off 期刊论文 CANCER SCIENCE, 2017, 卷号: 108, 期号: 10 作者:  Li, Jin;  Xu, Ruihua;  Xu, Jianming;  Denda, Tadamichi;  Ikejiri, Koji 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Clinical trial  colorectal neoplasms  leucovorin  pharmacokinetics  S-1 (combination)   A Phase I/II trial of fruquintinib in combination with paclitaxel for second-line treatment in patients with advanced gastric cancer 期刊论文 Journal of Clinical Oncology, 2017, 卷号: 35 作者:  Xu R.-H., Zhang D., Shen L., Li J., Huang J., Gong J., Guo W., Zhang Y., Fan S., Li K., Hua Y., Su W. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial 期刊论文 Journal of Clinical Oncology, 2017, 卷号: 35 作者:  null 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial 期刊论文 CHINESE JOURNAL OF CANCER, 2017, 卷号: 36 作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Ke-Ming;  Wu, Gang;  Shi, Chun-Mei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Colorectal cancer  Famitinib  Efficacy  Safety